nelfinavir has been researched along with Chronic Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colonno, R; Dicker, I; Fan, L; Gali, V; Higley, H; Krystal, M; Lin, PF; Nowicka-Sans, B; Parkin, N; Tenney, D; Terry, B; Wang, C; Zhang, S | 1 |
| Chichino, G; Donadel, E; Genco, F; Ladisa, N; Malicarne, L; Martini, S; Masala, A; Maserati, R; Meroni, V; Narciso, P; Occhino, C; Perini, P; Ravasi, G; Testa, L; Uglietti, A | 1 |
2 other study(ies) available for nelfinavir and Chronic Hepatitis B
| Article | Year |
|---|---|
Entecavir exhibits inhibitory activity against human immunodeficiency virus under conditions of reduced viral challenge.
Topics: Antiviral Agents; Cell Line; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans | 2008 |
Nelfinavir+M8 plasma levels determined with an ELISA test in HIV infected patients with or without HCV and/or HBV coinfection: the VIRAKINETICS II study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Plasma | 2009 |